A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects with Persistent Atrial Fibrillation

Go Back to All Clinical Trials

A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects with Persistent Atrial Fibrillation

Brief description of study

Prospective, single arm, open label, multi-center IDE pivotal study utilizing the FARAPULSE PFA System in the treatment of patients with Persistent Atrial Fibrillation (AF).

Patients treated with the FARAPULSE PFA system will be followed up for 12 months.

Clinical Study Identifier: s22-00328

ClinicalTrials.gov Identifier: NCT05443594

Principal Investigator: Larry A Chinitz.

Other Investigators: Sameer P Parekh, Chirag R. Barbhaiya.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies